Bipoláris zavar: vizsgálatok itt: India
6 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)
- Where
- Belagavi, Hyderabad, Kolkata, Kozhikode, Ludhiana, Madurai, Vadodara, Visakhapatnam
- Életkor
- 18 év to 65 év
- People
- 274 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06951711 - 2. fázisTaking peopleA Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)
- Where
- Belgavi, Bhopal, Chhatrapati Sambhajinagar, Dehradun, Dharwad, Lucknow, Mysore, Nashik, Pune, Tiruchirappalli, Varanasi
- Életkor
- 18 év to 75 év
- People
- 400 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07286175 - 3. fázisTaking peopleMulticenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
- Where
- Ahmedabad, Chhatrapati Sambhajinagar, Nashik, Varanasi
- Életkor
- 10 év to 17 év
- People
- 384 worldwide
- Run by
- Intra-Cellular Therapies, Inc.
See details and how to joinNCT06372964 - 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
- Where
- Kolkata, Madurai, Mangalore, Mangaluru
- Életkor
- 18 év to 65 év
- People
- 424 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07140913 - 3. fázisTaking peopleA Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
- Where
- Belagavi, Hyderabad, Kolkata, Kozhikode, Ludhiana, Madurai, Mangalore, Vadodara
- Életkor
- 18 év to 65 év
- People
- 450 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06929273 · EU 2024-520259-26-00 - 1/2. fázisTaking peoplePharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral Cariprazine
- Where
- Ahmedabad
- Életkor
- 18 év to 64 év
- People
- 24 worldwide
- Run by
- Mapi Pharma Ltd.
See details and how to joinNCT07185815